Suppr超能文献

墨西哥纯美洲印第安人拉坎东人中多发性硬化症和脱髓鞘疾病的缺失情况。

Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico.

作者信息

Flores Jose, González Silvia, Morales Ximena, Yescas Petra, Ochoa Adriana, Corona Teresa

机构信息

Neurodegenerative Diseases Laboratory, The National Institute of Neurology and Neurosurgery, Insurgentes Sur 3877 Col. La Fama. Del. Tlalpan, CP 14269, Mexico City 14000, DF, Mexico.

出版信息

Mult Scler Int. 2012;2012:292631. doi: 10.1155/2012/292631. Epub 2012 Aug 29.

Abstract

Multiple Sclerosis (MS) is a highly polymorphic disease characterized by different neurologic signs and symptoms. In MS, racial and genetic factors may play an important role in the geographic distribution of this disease. Studies have reported the presence of several protective alleles against the development of autoimmune disorders. In the case of MS, however, they help define MS as a complex disease, and confirm the importance of environmental agents as an independent variable not associated with ethnicity. We carried out an on-site epidemiological study to confirm the absence of MS or NMO among Lacandonians, a pure Amerindian ethnic group in Mexico. We administered a structured interview to 5,372 Lacandonians to assess by family background any clinical data consistent with the presence of a prior demyelinating event. Every participating subject underwent a comprehensive neurological examination by a group of three members of the research team with experience in the diagnosis and treatment of demyelinating disorders to detect clinical signs compatible with a demyelinating disease. We did not find any clinical signs compatible with multiple sclerosis among study participants.

摘要

多发性硬化症(MS)是一种高度多态性疾病,具有不同的神经体征和症状。在MS中,种族和遗传因素可能在该疾病的地理分布中起重要作用。研究报告了几种针对自身免疫性疾病发展的保护性等位基因的存在。然而,就MS而言,它们有助于将MS定义为一种复杂疾病,并证实环境因素作为与种族无关的独立变量的重要性。我们进行了一项现场流行病学研究,以确认墨西哥一个纯美洲印第安人族群拉坎顿人中是否不存在MS或视神经脊髓炎(NMO)。我们对5372名拉坎顿人进行了结构化访谈,以通过家族背景评估任何与既往脱髓鞘事件存在相符的临床数据。每位参与的受试者都接受了由一组三名在脱髓鞘疾病诊断和治疗方面有经验的研究团队成员进行的全面神经系统检查,以检测与脱髓鞘疾病相符的临床体征。在研究参与者中,我们未发现任何与多发性硬化症相符的临床体征。

相似文献

2
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
3
[Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Rinsho Shinkeigaku. 2010 Nov;50(11):788-93. doi: 10.5692/clinicalneurol.50.788.
4
Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population.
Rev Bras Reumatol Engl Ed. 2017 May-Jun;57(3):224-228. doi: 10.1016/j.rbre.2016.09.016. Epub 2016 Oct 25.
6
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Gene. 2014 Feb 25;536(2):302-7. doi: 10.1016/j.gene.2013.12.007. Epub 2013 Dec 18.
7
Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Mult Scler Relat Disord. 2017 Feb;12:39-43. doi: 10.1016/j.msard.2017.01.004. Epub 2017 Jan 6.
8
Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
Mult Scler Relat Disord. 2020 Oct;45:102399. doi: 10.1016/j.msard.2020.102399. Epub 2020 Jul 15.
9
Paediatric UK demyelinating disease longitudinal study (PUDDLS).
BMC Pediatr. 2011 Jul 28;11:68. doi: 10.1186/1471-2431-11-68.
10
Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis.
Brain Commun. 2022 Jul 9;4(4):fcac181. doi: 10.1093/braincomms/fcac181. eCollection 2022.

引用本文的文献

1
What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?
Front Immunol. 2022 Nov 17;13:1036155. doi: 10.3389/fimmu.2022.1036155. eCollection 2022.
3
Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
Immunogenetics. 2018 Aug;70(8):547-551. doi: 10.1007/s00251-018-1052-8. Epub 2018 Feb 3.
4
The genetics of multiple sclerosis in Latin America.
Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317727295. doi: 10.1177/2055217317727295. eCollection 2017 Jul-Sep.
5
Environmental factors influencing multiple sclerosis in Latin America.
Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715049. doi: 10.1177/2055217317715049. eCollection 2017 Apr-Jun.
6
Prevalence of multiple sclerosis in Latin America and its relationship with European migration.
Mult Scler J Exp Transl Clin. 2016 Sep 2;2:2055217316666407. doi: 10.1177/2055217316666407. eCollection 2016 Jan-Dec.
7
Multiple sclerosis care in Latin America.
Neurology. 2014 May 6;82(18):1660-1. doi: 10.1212/WNL.0000000000000376.
8
The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
Mult Scler Int. 2014;2014:545080. doi: 10.1155/2014/545080. Epub 2014 Feb 3.

本文引用的文献

1
Genetics of multiple sclerosis: swimming in an ocean of data.
Curr Opin Neurol. 2012 Jun;25(3):239-45. doi: 10.1097/WCO.0b013e3283533a93.
4
Association of a history of varicella virus infection with multiple sclerosis.
Clin Neurol Neurosurg. 2009 Jan;111(1):54-6. doi: 10.1016/j.clineuro.2008.07.007. Epub 2008 Oct 22.
5
Association between parasite infection and immune responses in multiple sclerosis.
Ann Neurol. 2007 Feb;61(2):97-108. doi: 10.1002/ana.21067.
6
Multiple sclerosis and the hygiene hypothesis.
Neurology. 2006 Dec 12;67(11):2085-6. doi: 10.1212/01.wnl.0000247663.40297.2d.
8
The genetic epidemiology of multiple sclerosis.
J Neuroimmunol. 2003 Oct;143(1-2):7-12. doi: 10.1016/j.jneuroim.2003.08.005.
9
Multiple susceptibility loci for multiple sclerosis.
Hum Mol Genet. 2002 Sep 15;11(19):2251-6. doi: 10.1093/hmg/11.19.2251.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验